4.5 Article

Human immunodeficiency virus case detection and antiretroviral therapy enrollment among children below and above 18 months old A comparative analysis from Cameroon

Journal

MEDICINE
Volume 100, Issue 17, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000025510

Keywords

adolescent; child; human immunodeficiency virus infection; human immunodeficiency virus testing; infants; polymerase chain reaction

Funding

  1. US National Institute of Health via Albert Einstein College of Medicine, Bronx, New York, USA (Central Africa IeDEA) [U01 AI096299]
  2. Else Kroener-Fresenius-Stiftung, Bad Homburg, Germany

Ask authors/readers for more resources

In comparison to children below 18 months, children aged 18 months and above showed higher rates of HIV testing, HIV positivity, and enrollment in ART treatment. This highlights the importance of prioritizing HIV testing for older children in order to achieve an AIDS-free generation.
While pediatric human immunodeficiency virus (HIV) testing has been more focused on children below 18 months through prevention of mother to child transmission of HIV (PMTCT), the yield of this approach remains unclear comparatively to testing children above 18 months through routine provider-initiated testing and counselling (PITC). This study aimed at assessing and comparing the HIV case detection and antiretroviral therapy (ART) enrolment among children below and above 18 months of age in Cameroon. This information is required to guide the investments in HIV testing among children and adolescents. We conducted a cross-sectional study where we invited parents visiting or receiving HIV care in 3 hospitals to have their children tested for HIV. HIV testing was done using polymerase chain reaction (PCR) and antibody rapid tests for children <18 months and those >= 18 months, respectively. We compared HIV case detection and ART initiation between the 2 subgroups of children and this using Chi-square test at 5% significant level. A total of 4079 children aged 6 weeks to 15 years were included in the analysis. Compared with children <18 months, children group >= 18 months was 4-fold higher among those who enrolled in the study (80.3% vs 19.7%, P < .001); 3.5-fold higher among those who tested for HIV (77.6% vs 22.4%, P < .001); 6-fold higher among those who tested HIV+ (85.7% vs 14.3%, P = .24), and 11-fold higher among those who enrolled on ART (91.7% vs 8.3%, P = .02). Our results show that 4 out of 5 children who tested HIV+ and over 90% of ART enrolled cases were children >= 18 months. Thus, while rolling out PCR HIV testing technology for neonates and infants, committing adequate and proportionate resources in antibody rapid testing for older children is a sine quo none condition to achieve an acquired immunodeficiency syndrome (AIDS)-free generation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available